Examining Real-World Evidence on Latest Therapies for Retinal Disease

Dr. London examines a case of longstanding bilateral neovascular age-related macular degeneration (AMD), focusing on the patient's clinical history, treatment challenges, and the potential impact of recent therapeutic advancements on management strategies.

Dr. London discusses the implications of faricimab and aflibercept 8 mg in treating retinal diseases, highlighting their mechanisms, efficacy data, and potential to enhance patient outcomes in conditions like wet age-related macular degeneration.

Dr. London discusses a case of diabetic macular edema (DME) with persistent subretinal fluid, emphasizing the diagnostic considerations, treatment options, and the implications for patient outcomes in the context of evolving therapeutic approaches.